These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8590594)

  • 1. The importance of Arg40 and 45 in the mitogenic activity and structural stability of basic fibroblast growth factor: effects of acidic amino acid substitutions.
    Arakawa T; Holst P; Narhi LO; Philo JS; Wen J; Prestrelski SJ; Zhu X; Rees DC; Fox GM
    J Protein Chem; 1995 Jul; 14(5):263-74. PubMed ID: 8590594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity.
    Heath WF; Cantrell AS; Mayne NG; Jaskunas SR
    Biochemistry; 1991 Jun; 30(22):5608-15. PubMed ID: 2036431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.
    Presta M; Statuto M; Isacchi A; Caccia P; Pozzi A; Gualandris A; Rusnati M; Bergonzoni L; Sarmientos P
    Biochem Biophys Res Commun; 1992 Jun; 185(3):1098-107. PubMed ID: 1378264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis.
    Li LY; Safran M; Aviezer D; Böhlen P; Seddon AP; Yayon A
    Biochemistry; 1994 Sep; 33(36):10999-1007. PubMed ID: 7522051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
    Thompson LD; Pantoliano MW; Springer BA
    Biochemistry; 1994 Apr; 33(13):3831-40. PubMed ID: 8142385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.
    Fannon M; Forsten KE; Nugent MA
    Biochemistry; 2000 Feb; 39(6):1434-45. PubMed ID: 10684625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.
    Isacchi A; Statuto M; Chiesa R; Bergonzoni L; Rusnati M; Sarmientos P; Ragnotti G; Presta M
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2628-32. PubMed ID: 1849269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
    Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL
    Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.
    Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP
    Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K; Rao VS; Qasba PK
    J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF2-Heparin co-crystal complex-assisted design of mutants FGF1 and FGF7 with predictable heparin affinities.
    Wong P; Burgess WH
    J Biol Chem; 1998 Jul; 273(29):18617-22. PubMed ID: 9660835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.
    Wong P; Hampton B; Szylobryt E; Gallagher AM; Jaye M; Burgess WH
    J Biol Chem; 1995 Oct; 270(43):25805-11. PubMed ID: 7592764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling and deletion mutagenesis implicate the nuclear translocation sequence in structural integrity of fibroblast growth factor-1.
    Luo Y; Gabriel JL; Wang F; Zhan X; Maciag T; Kan M; McKeehan WL
    J Biol Chem; 1996 Oct; 271(43):26876-83. PubMed ID: 8900171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
    Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA
    J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis.
    Zhu H; Ramnarayan K; Anchin J; Miao WY; Sereno A; Millman L; Zheng J; Balaji VN; Wolff ME
    J Biol Chem; 1995 Sep; 270(37):21869-74. PubMed ID: 7665610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis.
    Burgess WH; Shaheen AM; Hampton B; Donohue PJ; Winkles JA
    J Cell Biochem; 1991 Feb; 45(2):131-8. PubMed ID: 1711526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
    Klagsbrun M
    Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.